Who
Mostafa Ronaghi
Director
Company insider
Files Form 4 as: Director, Summit Therapeutics; Director, Seer; SVP, Entrepreneurial Devlopmt, Illumina.
In numbers
- Trades disclosed
- 308
- Buys
- 0
- Sells
- 35
- Bought
- $0
- Sold
- $72.3M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 4 Aug 2008
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 2 Jan 2025filed 6 Jan 2025 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 11 Apr 2024filed 15 Apr 2024 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 | filing |
| 11 Apr 2024filed 15 Apr 2024 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,315 | filing |
| 14 Jun 2023filed 16 Jun 2023 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code A | —34,735 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | SEER SeerLife-science tools | SEC FORM 4 Code A | —23,443 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code A | —29,640 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | SEER SeerLife-science tools | SEC FORM 4 Code A | —9,945 at $0.00 | filing |
| 16 Feb 2021filed 18 Feb 2021 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code A | —27,939 at $0.00 | filing |
| 10 Dec 2020filed 14 Dec 2020 | ILMN IlluminaLife-science tools | SEC FORM 4 Sold | $438K1,300 at $336.92 | filing |
| 10 Dec 2020filed 14 Dec 2020 | ILMN IlluminaLife-science tools | SEC FORM 4 Sold | $372K1,100 at $337.99 | filing |
| 10 Dec 2020filed 14 Dec 2020 | ILMN IlluminaLife-science tools | SEC FORM 4 Sold | $747K2,200 at $339.42 | filing |
| 10 Dec 2020filed 14 Dec 2020 | ILMN IlluminaLife-science tools | SEC FORM 4 Sold | $136K400 at $341.00 | filing |
| 5 Nov 2020filed 9 Nov 2020 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $365K1,171 at $311.72 | filing |
| 27 Jul 2020filed 29 Jul 2020 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $75K192 at $393.04 | filing |
| 11 Feb 2020filed 13 Feb 2020 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —5,864 at $0.00 | filing |
| 11 Feb 2020filed 13 Feb 2020 | ILMN IlluminaLife-science tools | SEC FORM 4 Code M | —11,728 at $0.00 | filing |
| 11 Feb 2020filed 13 Feb 2020 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $2.4M8,226 at $296.00 | filing |
| 11 Feb 2020filed 13 Feb 2020 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code M | —11,728 at $0.00 | filing |
News
Illumina's (ILMN) Sequencing Business Is Recovering, But Is the Stock Getting Ahead of Itself?ILMN · insidermonkey.com · 13 Oct 2026Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysILMN · themarketsdaily.com · 7 Oct 2026
0 headlines in the last 90 days name Mostafa Ronaghi; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.